CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
Sponsor: University Hospital, Clermont-Ferrand • ClinicalTrials.gov ID: NCT05051397
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Acute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occluded vessel. Mechanical thrombectomy is the standard of care for anterior circulation large vessel reperfusion. Strategy to promote cerebral blood flow in collateral circulation before reperfusion is scarce and rely mainly on blood pressure maintenance. Carbon dioxide is a potent cerebral vasodilator that could enhance collateral circulation blood flow and cerebral protection before reperfusion. General anesthesia with endotracheal mechanical ventilation could be used for thrombectomy and give the opportunity to modulate and control carbon dioxide tension in the blood. This study will test the effect of moderate hypercapnia on penumbral collateral circulation before reperfusion during mechanical thrombectomy for anterior circulation acute ischemic stroke under general anesthesia.
Interventions
-
HYPERCAPNIA
(Biological)
Controlled moderate hypercapnia PaCO2 50mmHg under general anesthesia with mechanical ventilation
-
NORMOCAPNIA
(Biological)
Controlled normocapnia PaCO2 40mmHg under general anesthesia with mechanical ventilation
Eligibility criteria
Conditions
Locations
- CHU — Clermont-Ferrand, France
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record